| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/28/2013 | US8450067 Method for obtaining anti-idiotype antibodies |
| 05/28/2013 | US8449979 Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof |
| 05/28/2013 | CA2515033C Clk-peptide and slk-peptide |
| 05/28/2013 | CA2423876C Novel selective bradykinin (bk) b1 peptidic receptor antagonists and uses thereof |
| 05/28/2013 | CA2338022C Inhibitors of hiv membrane fusion |
| 05/23/2013 | WO2013074820A1 Immunogenic tumor associated stromal cell antigen peptides and methods of their use |
| 05/23/2013 | WO2013074608A1 Cyclosporine a form 2 and method of making same |
| 05/23/2013 | WO2013072695A1 Polymyxin derivatives |
| 05/23/2013 | WO2013071396A1 Oral leptin formulations and uses thereof |
| 05/23/2013 | US20130133102 Targeting signal for integrating proteins, peptides and biological molecules into bacterial microcompartments |
| 05/23/2013 | US20130131314 Peptide Derivatives for Biofunctionalization of Silicon Substrates and Their Applications |
| 05/23/2013 | US20130131313 Eef2k assays for identifying compounds that inhibit eef2k activity |
| 05/23/2013 | US20130131311 Aziridine mediated native chemical ligation |
| 05/23/2013 | US20130130996 Peptides for inhibiting chemokine binding to chemokine receptors |
| 05/23/2013 | US20130130995 Treatments for Gastrointestinal Disorders |
| 05/23/2013 | US20130130994 Antimicrobial peptides and peptide derivatives derived from oncopeltus fasciatus |
| 05/23/2013 | US20130130989 Eif4e binding peptides |
| 05/23/2013 | US20130130987 Methods for inhibiting immune complex formation in a subject |
| 05/23/2013 | US20130130985 Oxytocin peptide analogues |
| 05/23/2013 | US20130130977 Polymer-based sustained release device |
| 05/23/2013 | US20130130976 Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases |
| 05/23/2013 | US20130130970 Lactadherin-derived peptides as antiviral agents |
| 05/23/2013 | US20130130969 Antimicrobial peptide, branched forms thereof and their use in the treatment of bacteria infections |
| 05/23/2013 | US20130130268 Epitopes of the human pdgf receptor able to bind human auto-antibodies, antibodies and uses thereof |
| 05/23/2013 | US20130130233 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 05/23/2013 | US20130129764 Compositions and methods to detect various infectious organisms |
| 05/23/2013 | US20130129760 Polypeptides |
| 05/23/2013 | US20130129759 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 05/23/2013 | US20130129753 Cytotoxic peptides and antibody drug conjugates thereof |
| 05/23/2013 | US20130129736 Aspp2 splicing variant |
| 05/23/2013 | US20130129715 Use of anti-plac1 protein antibodies as biomarkers of infertility, diagnostic kit for the detection of the immune response against plac1 and use of plac1 protein in therapeutic and contraceptive fields |
| 05/23/2013 | US20130129714 Prevention and treatment of cast nephropathy |
| 05/23/2013 | US20130129689 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 05/23/2013 | US20130129622 Cyclopentapeptide derivatives and uses thereof |
| 05/23/2013 | US20130129621 Integrin Receptor Antagonists and Their Methods of Use |
| 05/23/2013 | CA2856034A1 Cyclosporine a form 2 and method of making same |
| 05/23/2013 | CA2855916A1 Polymyxin derivatives |
| 05/23/2013 | CA2855545A1 Oral leptin formulations and uses thereof |
| 05/23/2013 | CA2852860A1 Cytotoxic peptides and antibody drug conjugates thereof |
| 05/22/2013 | EP2593546A1 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction |
| 05/22/2013 | EP2593121A2 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF |
| 05/22/2013 | CN103119052A Peptide derivatives, preparation thereof and uses thereof |
| 05/22/2013 | CN103113877A Fluorescent probe for detecting microcystic toxin-LR in water |
| 05/22/2013 | CN103113458A Hepatitis c virus B-cell epitope peptide PUHI34 and application thereof |
| 05/22/2013 | CN103113457A Antagonistic peptide SA-12 and application thereof in medicament for treating breast cancer |
| 05/22/2013 | CN103113456A Stiff silkworm polypeptide with antiplatelet aggregation activity as well as preparation method and application of stiff silkworm polypeptide |
| 05/21/2013 | US8445632 Selective poly-N-substituted glycine antibiotics |
| 05/21/2013 | US8445441 Inhibitors of BCL-2 |
| 05/21/2013 | US8445006 Biomolecular coating for implants |
| 05/21/2013 | CA2477675C Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein |
| 05/21/2013 | CA2401638C Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 05/16/2013 | WO2013071154A1 Cyclin a1-targeted t-cell immunotherapy for cancer |
| 05/16/2013 | WO2013071049A1 Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity |
| 05/16/2013 | WO2013071039A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis |
| 05/16/2013 | WO2013070531A1 Compositions and methods for inhibiting the interaction between cftr and cal |
| 05/16/2013 | US20130123465 Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus |
| 05/16/2013 | US20130123464 Ceacam based antibacterial agents |
| 05/16/2013 | US20130123460 Peptide for improving biostability of bioactive substance, and bioactive substance having improved biostability |
| 05/16/2013 | US20130123202 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 05/16/2013 | US20130123197 Crystal of Peptide Substance as well as the Preparation Method and Use Thereof |
| 05/16/2013 | US20130123196 Thioether-, ether-, and alkylamine-linked hydrogen bond surrogate peptidomimetics |
| 05/16/2013 | US20130123193 Cyclosporin a form 2 and method of making same |
| 05/16/2013 | US20130123192 Compositions and methods for inhibiting matrix metalloproteinase (mmp)-mediated cell migration |
| 05/16/2013 | US20130123187 Peptides for the regulation of neurotransmitter sequestration and release |
| 05/16/2013 | US20130123186 Neuroprotection using nap-like and sal-like peptide mimetics |
| 05/16/2013 | US20130123170 Growth Hormone Releasing Peptides |
| 05/16/2013 | US20130123140 Identification of compounds modifying a cellular response |
| 05/16/2013 | US20130122546 Novel signal peptide, and use thereof for producing recombinant proteins |
| 05/16/2013 | US20130122030 S. epidermidis antigens |
| 05/16/2013 | US20130122029 Cancer vaccine |
| 05/16/2013 | US20130122024 New binder-drug conjugates (adcs) and use thereof |
| 05/16/2013 | US20130121935 Novel caspase-14 activator peptides and compositions comprising said peptides |
| 05/16/2013 | CA2855358A1 Cyclin a1-targeted t-cell immunotherapy for cancer |
| 05/15/2013 | EP2592088A1 Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 05/15/2013 | EP2590992A2 Mu opioid receptor agonist analogs of the endomorphins |
| 05/15/2013 | CN103103242A Antioxidant active peptide and preparation method thereof |
| 05/15/2013 | CN103102396A Novel thiostrepton analog, amd preparation method and application thereof |
| 05/15/2013 | CN103102395A Preparation method of desmopressin acetate |
| 05/15/2013 | CN103102394A B cell epitope peptide PUHI49 for hepatitis c virus (HCV) and application of B cell epitope peptide PUHI49 |
| 05/15/2013 | CN103102393A Polypeptide and application of polypeptide in preparation of drug used for treating depression |
| 05/15/2013 | CN103102392A N-terminal polypeptide of retinoic acid induced protein 16 and preparation method and application of antibody thereof |
| 05/15/2013 | CN103102391A Antigenic mimic epitope of norfloxacin and application thereof |
| 05/15/2013 | CN103102390A Preparation method for octreotide |
| 05/15/2013 | CN103102389A Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease |
| 05/15/2013 | CN101657465B Peptides, compositions and uses thereof |
| 05/15/2013 | CN101379075B Synthesis of glucagon-like peptide |
| 05/14/2013 | US8440794 Peptide sequences, their branched form and use thereof for antimicrobial applications |
| 05/14/2013 | US8440793 Peptide analogs of alpha-melanocyte stimulating hormone |
| 05/14/2013 | US8440792 Antimicrobial peptides and derived metapeptides |
| 05/14/2013 | US8440630 Akt activity specifically inhibiting polypeptide |
| 05/14/2013 | US8440626 Antineoplastic peptides |
| 05/14/2013 | US8440624 Peptide whitening agents and cosmetic compositions comprising the same |
| 05/14/2013 | US8440201 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 05/14/2013 | CA2477878C Peptides selectively lethal to malignant and transformed mammalian cells |
| 05/14/2013 | CA2441562C Short bioactive peptides and methods for their use |
| 05/14/2013 | CA2419469C Derivatives of peptides and peptide mimetics having integrin inhibitor properties ii |
| 05/14/2013 | CA2365639C Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
| 05/10/2013 | WO2013067391A1 Fluorescent substrates for determining lysine modifying enzyme activity |
| 05/10/2013 | WO2013067160A2 Anti-bacterial polypeptides and pathogen specific synthetic antibodies |
| 05/10/2013 | WO2013065832A1 Dpp-4 inhibitor |